Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Long

Showing results (1411-1420 of 1,900) with videos related to

Pageof 190
Sort By:
Clinical and Experimental Immunology|April 23, 2013
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetesJ B Bollyky, S A Long, M Fitch, et al.
Journal of Lipid Research|October 1, 1994
Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeysC A Marzetta, Y E Savoy, A M Freeman, et al.
Journal of Medicinal Chemistry|November 25, 1994
An evaluation of the antirhinoviral activity of acetylfuran replacements for 3-methylisoxazoles. Are 2-acetylfurans bioisosteres for 3-methylisoxazoles?T R Bailey, G D Diana, J P Mallamo, et al.
Circulation|March 11, 2025
Sex Differences in Peripheral Vascular Disease: A Scientific Statement From the American Heart AssociationEsther S H Kim, Shipra Arya, Yolanda Bryce, et al.
Kidney International|August 31, 2016
Loss of endogenous thymosin β<sub>4</sub> accelerates glomerular diseaseElisavet Vasilopoulou, Maria Kolatsi-Joannou, Maja T Lindenmeyer, et al.
The Journal of Allergy and Clinical Immunology|September 19, 2016
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthmaCarlos Iribarren, Abdelkader Rahmaoui, Aidan A Long, et al.
Malaria Journal|September 4, 2019
Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mLGeneviève M Labbé, Kazutoyo Miura, Sarah E Silk, et al.
Viruses|April 13, 2018
Characterizing Phage Genomes for Therapeutic ApplicationsCasandra W Philipson, Logan J Voegtly, Matthew R Lueder, et al.
Infection and Immunity|September 5, 2013
RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigenDaisuke Ito, Tomoyuki Hasegawa, Kazutoyo Miura, et al.
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
Pageof 190

Showing results (1411-1420 of 1,900) with videos related to

Sort By:
Pageof 190
Clinical and Experimental Immunology|April 23, 2013
Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetesJ B Bollyky, S A Long, M Fitch, et al.
Journal of Lipid Research|October 1, 1994
Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeysC A Marzetta, Y E Savoy, A M Freeman, et al.
Journal of Medicinal Chemistry|November 25, 1994
An evaluation of the antirhinoviral activity of acetylfuran replacements for 3-methylisoxazoles. Are 2-acetylfurans bioisosteres for 3-methylisoxazoles?T R Bailey, G D Diana, J P Mallamo, et al.
Circulation|March 11, 2025
Sex Differences in Peripheral Vascular Disease: A Scientific Statement From the American Heart AssociationEsther S H Kim, Shipra Arya, Yolanda Bryce, et al.
Kidney International|August 31, 2016
Loss of endogenous thymosin β<sub>4</sub> accelerates glomerular diseaseElisavet Vasilopoulou, Maria Kolatsi-Joannou, Maja T Lindenmeyer, et al.
The Journal of Allergy and Clinical Immunology|September 19, 2016
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthmaCarlos Iribarren, Abdelkader Rahmaoui, Aidan A Long, et al.
Malaria Journal|September 4, 2019
Harmonization study between three laboratories for expression of malaria vaccine clinical trial IgG antibody ELISA data in µg/mLGeneviève M Labbé, Kazutoyo Miura, Sarah E Silk, et al.
Viruses|April 13, 2018
Characterizing Phage Genomes for Therapeutic ApplicationsCasandra W Philipson, Logan J Voegtly, Matthew R Lueder, et al.
Infection and Immunity|September 5, 2013
RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigenDaisuke Ito, Tomoyuki Hasegawa, Kazutoyo Miura, et al.
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
Pageof 190